Browsed by
Tag: New Mexico

Collaborator Spotlight: New Mexico Investigators on the #4Corners4Health Project

Collaborator Spotlight: New Mexico Investigators on the #4Corners4Health Project

More than a dozen scientists from universities and NCI Comprehensive Cancer Centers in Arizona, Colorado, New Mexico, and Utah are collaborating with Dr. David Buller, Klein Buendel’s Director of Research, on the #4Corners4Health study (CA268037). This Collaborator Spotlight features the Investigators from the State of New Mexico.

The 4Corners study aims to aid rural emerging adults (ages 18-26 years) in making informed decisions that reduce cancer risk factors and prevent cancer later in life and help emerging adults evaluate and resist misinformation and marketing that promote cancer risk behaviors. This will be accomplished using a social media campaign designed with community advisors for diverse young adults living in rural counties in the Four Corners states (AZ, CO, NM, and UT). Social media may reach emerging adults more than interventions through other community channels (for example, clinics, schools, and workplaces) and for lower cost in the geographically dispersed, underserved rural communities in the Mountain West.

Andrew Sussman, PhD, MCRP, is a medical anthropologist and an Associate Professor in the Department of Family Community Medicine and the  Associate Director for Community Outreach and Engagement at the University of New Mexico Comprehensive Cancer Center (Cancer Control and Population Sciences). At the Cancer Center, he served as the Founding Director of the Behavioral Measurement and Population Science Shared Resource.

Dr. Sussman has expertise in qualitative and mixed method research, formative assessment, and process evaluation. His research focuses on cancer care delivery research, patient-provider communication, clinical decision making, health service delivery, community-based participatory research, and health disparities in primary care and community settings. He has received funding to conduct research on cancer prevention, obesity and diabetes, substance use, and complementary and alternative medicine, among other topics.

In addition to research, he teaches and mentors students, and serves on several university committees, including evaluating the Physician Assistant Program in the Department of Family and Community Medicine and the Advancing Institutional Mentoring Excellence Program through the Office for Diversity.

Cindy Blair, MPH, PhD, is an epidemiologist and an Associate Professor in the Department of Internal Medicine at the University of New Mexico. She also has an appointment at the Comprehensive Cancer Center in Cancer Control and Population Sciences.

Dr. Blair’s research focuses on developing lifestyle behavior change interventions to improve the physical health and quality of life of cancer survivors. Her primary research interests include physical activity and the interface between aging and cancer, including interventions that utilize a whole-of-day approach to physical activity. This approach focuses on increasing light-intensity activity throughout the day, while reducing and disrupting sedentary activity. Her research includes the development of home- and technology-based interventions to reach the underserved and understudied survivor populations, especially older individuals from racial-ethnic minorities and rural dwellers, who may be unable to travel to clinical research centers to participate in research studies.

She has received a Career Development Award (K07) from the National Cancer Institute (2018-2023) and completed a Postdoctoral Research Fellowship (R25) with the National Cancer Institute Cancer Prevention and Control Training Program (2011-2013).

Melanoma Receptor Variation in a New Mexico Population

Melanoma Receptor Variation in a New Mexico Population

Dr. David Buller, KB Senior Scientist and Director of Research, is a co-author on a paper published recently in Cancer Epidemiology, Biomarkers & Prevention. The paper examines the Melanocortin 1 Receptor (MC1R) in a multicultural New Mexican population. MC1R is a risk factor for developing melanoma skin cancer because it contributes to skin pigmentation. The paper’s lead author is Dr. Kirsten White from the University of New Mexico. Other co-authors are from the Memorial Sloan Kettering Cancer Center in New York, the University of Utah, and the University of New Mexico.

Specifically, single-nucleotide polymorphisms (SNPs) in MC1R and their association with race and ethnicity, skin type, and perceived cancer risk were evaluated by genotyping MC1R in 191 primary care clinic patients in Albuquerque, New Mexico. A full description of the methods, results, conclusions, and limitations of the research can be found in the publication.

Overall, the authors concluded that a specific variant of interest in MC1R may not be a risk factor for melanoma among New Mexican Hispanics, and that genetic risk cannot be inferred from Northern European populations directly to non-European populations.